AiA Feed
A
Anthony Ha

The musician-turned-biotech-founder waiting to fundraise

Grammy-nominated musician Aloe Blacc discovered that personal funding cannot navigate the regulatory and commercialization barriers of biotech drug development. He's now bootstrapping a pancreatic cancer drug platform after realizing philanthropy can finance research but not clinical trials or regulatory approval. His journey reveals a critical gap for biotech founders: capital is abundant, but regulatory expertise is the limiting factor.See more

5dAnthony Ha
A
Anthropic News (via RSSHub)

Anthropic's Long-Term Benefit Trust appoints Vas Narasimhan to Board of Directors

Vas Narasimhan, Novartis CEO and physician-scientist, has joined Anthropic's Board via the Long-Term Benefit Trust, which now holds board majority. With 35+ years shepherding breakthrough medicines through regulated industries, Narasimhan brings expertise in scaling transformative technology responsibly. The appointment strengthens governance oversight aligned with Anthropic's public benefit mission as it grows.See more

7dAnthropic News (via RSSHub)
A
Anthony Ha

Anthropic co-founder confirms the company briefed the Trump administration on Mythos

Anthropic co-founder Jack Clark revealed at the Semafor World Economy summit that the company briefed the Trump administration on Mythos while simultaneously suing the U.S. government. The seemingly contradictory approach—engaging with policymakers while mounting legal challenges—reflects how AI companies now navigate a complex regulatory landscape. This highlights the strategic imperative for AI companies to maintain multiple pathways with government stakeholders during policy formulation.See more

6dAnthony Ha
AiA Feed · Generated with AI, which can make mistakes.